Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-17

Clinical Trial Update: Lidocaine 5% Patch (Lidoderm) for the Prevention of Acute and Chest Pain Following Robotic Valve Surgery [NA]

View source ↗

Summary

Completed clinical trial evaluating lidocaine 5% patch (Lidoderm) to prevent acute and chest pain after robotic valve surgery; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine 5% patch (Lidoderm) (lidocaine 5% patch)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Perioperative Chest Pain | NA | Status: COMPLETED | Results posted: 2020-04-17